Chord Energy Corporation (the "Company," "we," "us,' or "our"), today announced the expiration of its cash tender offer to purchase (the "Offer") any and all of the outstanding 6.375% senior notes due ...

Annual net revenue increased 4% to $267.0 million in 2024, despite significant divestitures –– UDENYCA® net revenue increased 62% ...

Shares of Novo Nordisk (NVO) are sliding in Monday trading after the company announces results for its trial of weight-loss drug CagriSema.

Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its ...